1. Home
  2. CDIO vs MTR Comparison

CDIO vs MTR Comparison

Compare CDIO & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • MTR
  • Stock Information
  • Founded
  • CDIO 2017
  • MTR 1979
  • Country
  • CDIO United States
  • MTR United States
  • Employees
  • CDIO N/A
  • MTR N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • MTR Oil & Gas Production
  • Sector
  • CDIO Health Care
  • MTR Energy
  • Exchange
  • CDIO Nasdaq
  • MTR Nasdaq
  • Market Cap
  • CDIO 7.9M
  • MTR 9.4M
  • IPO Year
  • CDIO N/A
  • MTR N/A
  • Fundamental
  • Price
  • CDIO $3.61
  • MTR $5.53
  • Analyst Decision
  • CDIO Buy
  • MTR
  • Analyst Count
  • CDIO 1
  • MTR 0
  • Target Price
  • CDIO $60.00
  • MTR N/A
  • AVG Volume (30 Days)
  • CDIO 56.5K
  • MTR 171.4K
  • Earning Date
  • CDIO 08-11-2025
  • MTR 01-01-0001
  • Dividend Yield
  • CDIO N/A
  • MTR 3.97%
  • EPS Growth
  • CDIO N/A
  • MTR N/A
  • EPS
  • CDIO N/A
  • MTR 0.23
  • Revenue
  • CDIO $19,902.00
  • MTR $668,826.00
  • Revenue This Year
  • CDIO $1,434.82
  • MTR N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • MTR N/A
  • P/E Ratio
  • CDIO N/A
  • MTR $23.32
  • Revenue Growth
  • CDIO N/A
  • MTR N/A
  • 52 Week Low
  • CDIO $3.22
  • MTR $4.70
  • 52 Week High
  • CDIO $53.10
  • MTR $10.42
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 32.36
  • MTR 49.61
  • Support Level
  • CDIO $3.65
  • MTR $5.06
  • Resistance Level
  • CDIO $4.18
  • MTR $10.42
  • Average True Range (ATR)
  • CDIO 0.31
  • MTR 0.89
  • MACD
  • CDIO 0.12
  • MTR -0.08
  • Stochastic Oscillator
  • CDIO 4.49
  • MTR 11.25

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: